<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04876976</url>
  </required_header>
  <id_info>
    <org_study_id>MS 75/2018</org_study_id>
    <nct_id>NCT04876976</nct_id>
  </id_info>
  <brief_title>Isoamyl 2-Cyanoacrylate in the Urethro-cutaneous Fistula Repair</brief_title>
  <official_title>Isoamyl 2-Cyanoacrylate Interposition in the Urethro-cutaneous Fistula Repair: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      cyanoacrylate has an impact that may aid in the successful repair of urethra-cutaneous&#xD;
      fistula (UCF) that occur after hypospadias surgical repair&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypospadias is a common congenital urological birth defect. Urethro-cutaneous fistula (UCF)&#xD;
      is the most common complication of surgical repair hypospadias and it remains the primary&#xD;
      concern of surgeons dealing with hypospadias repair.&#xD;
&#xD;
      cyanoacrylate has been reported to enhance the healing process. this study tries to evaluate&#xD;
      the clinical impact of cyanoacrylate on the repair of urethro-cutaneous fistula after&#xD;
      surgical repair of hypospadias&#xD;
&#xD;
      this study evaluates the impact of using cyanoacrylate as an interposition substance in&#xD;
      surgical repair of UCF after hypospadias in comparison to the classic surgical repair&#xD;
      technique&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Cases of group (I) underwent multilayered closure using dartos facial flap and cyanoacrylate glue as an interposition layer.&#xD;
Cases of the control group (II) underwent the same procedure without using cyanoacrylate.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>patients and their relatives were blinded to the type of the intervention</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>successful repair of the fistula</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>surgical outcome regarding the repair of urethro-cutaneous fistula, whether adequate healing occurred or recurrence is present</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>report of the possible postoperative complications of both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Hypospadias</condition>
  <arm_group>
    <arm_group_label>Cases of group (I) cyanoacrylate glue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cases of group (I) underwent multilayered closure using dartos facial flap and cyanoacrylate glue as an interposition layer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cases of the control group (II) , classic repair</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cases of the control group (II) underwent the same procedure without using cyanoacrylate.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyanoacrylate, Isobutyl</intervention_name>
    <description>using cyanoacrylate in the surgical repair of urethro-cutaneous fistula</description>
    <arm_group_label>Cases of group (I) cyanoacrylate glue</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Classic surgical repair</intervention_name>
    <description>classical repair of urethro-cutaneous fistula without the use of cyanoacryalte</description>
    <arm_group_label>Cases of the control group (II) , classic repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with Urethro-cutaneous fistula regardless of their age were included in our&#xD;
             study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with fistula size more than 5 mm&#xD;
&#xD;
          -  multiple fistulas&#xD;
&#xD;
          -  uncorrected obstruction distal to the fistula&#xD;
&#xD;
          -  necrotic tissue&#xD;
&#xD;
          -  active infection at the fistula site&#xD;
&#xD;
          -  severely scarred skin&#xD;
&#xD;
          -  deficient dartos around the fistula&#xD;
&#xD;
          -  fistulas more proximal to the mid penile position&#xD;
&#xD;
          -  recurrent fistulas&#xD;
&#xD;
          -  previous history of hypersensitivity to cyanoacrylate-based products&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Hypospadias is a male urethral congenital anomaly</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Urology department - ain shams university</name>
      <address>
        <city>Cairo</city>
        <zip>11361</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>May 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ahmed Maher Gamil Ahmed Higazy</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>Isoamyl 2-cyanoacrylate</keyword>
  <keyword>urethrocutaneous fistula</keyword>
  <keyword>fistula repair</keyword>
  <keyword>hypospadias</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypospadias</mesh_term>
    <mesh_term>Cutaneous Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

